Author and Publication
Author: Ben Slater, Registered Social Worker, Founder and Managing Director of Nellie Supports
Reviewed by: Kerry Slater, Director of Operations
Last reviewed: 20 July 2026
Citation
1. Department of Health and Social Care (2022) National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care. Available at: https://www.gov.uk/government/publications/national-framework-for-nhs-continuing-healthcare-and-nhs-funded-nursing-care
2. Department of Health and Social Care (2022) NHS Continuing Healthcare Decision Support Tool.
3. National Institute for Health and Care Excellence. Clinical guidance. Available at: https://www.nice.org.uk
4. R v North and East Devon Health Authority, ex parte Coughlan [2000] 2 WLR 622.
Copywright
Copyright © 2026 Nellie Supports Ltd. All rights reserved.
This article is made available for general information, education and professional reference. It may be downloaded, printed and shared for non-commercial purposes, provided that it is reproduced in full, is not altered in any way, and is properly cited as the work of Nellie Supports Ltd. This material must not be edited, adapted, sold, republished, incorporated into commercial products, or used for commercial training, assessment, report-writing or advisory services without prior written permission from Nellie Supports Ltd.
This article does not constitute legal advice, clinical advice or a substitute for a decision-specific professional assessment. Where legislation, government guidance, court forms or external professional materials are referred to, those materials remain subject to their own copyright, licensing and re-use terms.
Abstract
This guide explains how NHS Continuing Healthcare eligibility is assessed where a person has cancer. It covers when the Fast Track route applies, the position for people living with cancer over a longer period, treatment effects, symptom control, the needs arising from advanced disease, and the evidence that supports an accurate assessment.
Cancer and NHS Continuing Healthcare funding
Cancer is the condition most associated with Fast Track, and for good reason. But many people live with advanced cancer for a considerable period, and for them the standard route is the relevant one.
Consider Fast Track first
Where the condition is deteriorating rapidly and may be entering a terminal phase, an appropriate clinician can complete a Fast Track Pathway Tool and funding should follow urgently, with no Checklist or Decision Support Tool required. Oncology and palliative care teams complete many of these. Where the trajectory is clear, this is by far the quicker route.
When the standard route applies
Where a person is living with advanced or metastatic disease over a longer period, is receiving ongoing treatment, or has significant needs arising from disease or treatment without a rapidly deteriorating trajectory, the standard assessment applies. Being told to wait for Fast Track can waste months in that situation.
Treatment effects
Chemotherapy, radiotherapy, immunotherapy and surgery all produce needs in their own right, including fatigue, neuropathy, lymphoedema, nausea, immunosuppression and infection risk. Where treatment leaves a person substantially dependent between cycles, that is assessed need and should be recorded rather than treated as temporary.
Symptom control
Pain, nausea, breathlessness and agitation may require complex regimes, frequent as required medication and repeated adjustment. Where a syringe driver is in use, that requires trained management and monitoring. Difficult symptom control engages the medication domain, which can reach priority, and speaks to nature and complexity.
Needs from advanced disease
Bone metastases bringing fracture risk and pain, brain metastases bringing cognitive change, seizures and behavioural change, spinal cord compression, malignant wounds requiring specialist dressing, and lymphoedema management. Each engages specific domains and each is frequently recorded only in clinical correspondence rather than in the assessment.
Fluctuation across treatment cycles
A person may be reasonably independent early in a cycle and highly dependent later, which is a fluctuation pattern assessments regularly miss. State where in the cycle the assessment took place and describe the range across the whole cycle rather than the day of the meeting.
Key takeaway
Ask about Fast Track first where the trajectory is deteriorating. Where it is not, use the standard route rather than waiting. Record treatment effects and cycle fluctuation, and carry the needs from advanced disease out of clinical letters and into the domains.
Add a Title
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Add a Title
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Frequently asked questions
Should we use Fast Track for cancer?
Where the condition is deteriorating rapidly and may be entering a terminal phase, yes, and oncology or palliative care teams complete many of these tools. Where the trajectory is not rapid, the standard route applies.
What if we are told to wait for Fast Track?
Where the person is living with advanced disease over a longer period, waiting can waste months. Request a Checklist so the standard route runs in parallel.
Do treatment side effects count?
Yes. Fatigue, neuropathy, lymphoedema, nausea and infection risk are assessed needs. Where treatment leaves someone substantially dependent between cycles, that should be recorded rather than treated as temporary.
Related NHS Continuing Healthcare pages
These links take you to the most relevant Nellie Supports service page and to the supporting guides that explain the surrounding process.
Speak to an independent CHC specialist
Nellie Supports prepares independent needs evidence for NHS Continuing Healthcare assessments, reviews and appeals across England and Wales. Our reports are written by registered social workers on a permanent employed team, with internal peer review before release. Call 0333 987 5118 or send an enquiry and we will talk through where you are in the process.